ADVANCED NSCLC
Clinical trials for ADVANCED NSCLC explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NSCLC trials appear
Sign up with your email to follow new studies for ADVANCED NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing a new drug called JS207, given alone or combined with other medications, for people with advanced non-small cell lung cancer. It's for patients whose cancer has continued to grow despite receiving standard chemotherapy and immunotherapy. The main goal is to …
Matched conditions: ADVANCED NSCLC
Phase: PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Doctors train Patients' own cells to fight lung cancer in new trial
Disease control Recruiting nowThis study is testing a personalized cell therapy for adults with advanced non-small cell lung cancer that has stopped responding to standard treatments. Doctors remove a patient's tumor, grow special immune cells from it in a lab, and then infuse a large number of these 'tumor-f…
Matched conditions: ADVANCED NSCLC
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC